Treatment options for epileptic myoclonus and epilepsy syndromes associated with myoclonus

@article{Andrade2009TreatmentOF,
  title={Treatment options for epileptic myoclonus and epilepsy syndromes associated with myoclonus},
  author={Danielle M. Andrade and Clement Hamani and Berge A. Minassian},
  journal={Expert Opinion on Pharmacotherapy},
  year={2009},
  volume={10},
  pages={1549 - 1560}
}
Background: Myoclonus is a brief shock-like movement that has many different etiologies. The degree to which it disturbs quality of life is extremely variable, as is its response to treatment. Objective: In this review, we focus on the treatment strategies for epileptic myoclonus in some common disorders, and in others that are not so common but where myoclonus is a prominent feature and has been studied more. Methods: An extended literature review in the English language was conducted through… 
Tremor and myoclonus.
A pilot open‐label trial of zonisamide in Unverricht‐Lundborg disease
TLDR
It is suggested that add‐on zonisamide (ZNS) may be a valuable therapeutic option in EPM1 patients and a significant reduction of myoclonus severity was reached after ZNS introduction.
Sustained Effect of Botulinum Neurotoxin in Myoclonus Owing to Epilepsia Partialis Continua
TLDR
Epilepsia partialis continua is defined as continuous myoclonic jerking of a body part of cortical origin and often resembles a movement disorder and the effect of botulinum neurotoxin (BoNT) therapy in EPC is controversial.
Spinal Myoclonus Developed during Cervical Epidural Drug Infusion in Postherpetic Neuralgia Patient
TLDR
A case of myoclonus during continuous epidural block with ropivacaine, morphine, and ketamine in an acute zoster patient is reported.
Rhinorrhea: A common nondopaminergic feature of Parkinson's disease
TLDR
Rhinorrhea is a common nondopaminergic feature of PD, unrelated to olfactory or motor deficits, and further investigations are needed to determine if rhinorrhea correlates with sympathetic denervation or other autonomic symptoms in PD.
Rhinorrhea: A Common Nondopaminergic Feature of Parkinson’s Disease
TLDR
Rhinorrhea is a common nondopaminergic feature of PD, unrelated to olfactory or motor deficits, and further investigations are needed to determine if rhinorrhea correlates with sympathetic denervation or other autonomic symptoms in PD.
Etude du gène KCTD7 associé à une épilepsie myoclonique progressive familiale
TLDR
Dans cet intervalle, contenant environ 85 genes annotes, nous avons sequence le gene KCTD7 car il s’agit de l’acronyme pour K+ Channel Tetramerization Domain 7, speculant sur une interaction potentielle avec un canal potassique.

References

SHOWING 1-10 OF 160 REFERENCES
Zonisamide for progressive myoclonus epilepsy: long-term observations in seven patients
Treatment Strategies for Myoclonic Seizures and Epilepsy Syndromes with Myoclonic Seizures
TLDR
Because myoclonic seizures can be difficult to treat, clinicians should be flexible in their approach and tailor therapy to each patient.
Juvenile Myoclonic Epilepsy: Long‐Term Response to Therapy
TLDR
With accurate diagnosis and appropriate therapy, seizures in JME can be adequately controlled, although JME is a chronic disorder that may require lifelong therapy, and patient management must also focus on patient lifestyle to minimize relapse.
Treatment of Lennox-Gastaut syndrome.
TLDR
The optimum treatment for Lennox-Gastaut syndrome remains uncertain and no study to date has shown any one drug to be highly efficacious; lamotrigine, topiramate and felbamate may be helpful as add-on therapy.
Myoclonus and epilepsy in childhood: A review of treatment with valproate, ethosuximide, lamotrigine and zonisamide
  • S. Wallace
  • Psychology, Medicine
    Epilepsy Research
  • 1998
Piracetam in the treatment of cortical myoclonus.
TLDR
The authors present their experience of 12 patients with progressive myoclonus epilepsy in whom the administration of up to 45 g piracetam daily, when added to existing anti-epileptic treatment, caused marked and sometimes spectacular improvement and was without significant adverse effects.
Epilepsy with Myoclonic absences
Development of myoclonus in patients with partial epilepsy during treatment with vigabatrin: an electroencephalographic study
TLDR
Data indicate that, although occurring rarely, it is possible to have epileptic myoclonus during GVG treatment, and a shift in the anti/proconvulsant GABAergic balance towards the latter may compromise the therapeutic effect of GVG.
Benign myoclonic epilepsy in infancy: neuropsychological and behavioural outcome
...
...